Carl-Henrik Heldin
E174116
Carl-Henrik Heldin is a Swedish molecular biologist renowned for his research on cell growth and cancer, particularly involving platelet-derived growth factor (PDGF), and for his leadership roles in major scientific institutions.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Carl-Henrik Heldin canonical | 3 |
How this entity was disambiguated
This entity first appeared as the object of triple T1510284 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Carl-Henrik Heldin Context triple: [Uppsala University, hasNotableAlumnus, Carl-Henrik Heldin]
-
A.
Sune Bergström
Sune Bergström was a Swedish biochemist and Nobel laureate recognized for his pioneering research on prostaglandins and other biologically active lipids.
-
B.
Holger Crafoord
Holger Crafoord was a Swedish industrialist and philanthropist whose endowment led to the creation of the prestigious Crafoord Prize in scientific research.
-
C.
Sigfrid Edström
Sigfrid Edström was a Swedish industrialist and sports administrator who served as president of the International Olympic Committee in the mid-20th century.
-
D.
Karl-Henrik Robèrt
Karl-Henrik Robèrt is a Swedish oncologist and sustainability pioneer best known as the founder of The Natural Step framework for strategic sustainable development.
-
E.
Carl Emil Wilhelm Andersson
Carl Emil Wilhelm Andersson, better known as Carl Milles, was a prominent Swedish sculptor renowned for his expressive fountains and monumental public works in the early 20th century.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Carl-Henrik Heldin Target entity description: Carl-Henrik Heldin is a Swedish molecular biologist renowned for his research on cell growth and cancer, particularly involving platelet-derived growth factor (PDGF), and for his leadership roles in major scientific institutions.
-
A.
Sune Bergström
Sune Bergström was a Swedish biochemist and Nobel laureate recognized for his pioneering research on prostaglandins and other biologically active lipids.
-
B.
Holger Crafoord
Holger Crafoord was a Swedish industrialist and philanthropist whose endowment led to the creation of the prestigious Crafoord Prize in scientific research.
-
C.
Sigfrid Edström
Sigfrid Edström was a Swedish industrialist and sports administrator who served as president of the International Olympic Committee in the mid-20th century.
-
D.
Karl-Henrik Robèrt
Karl-Henrik Robèrt is a Swedish oncologist and sustainability pioneer best known as the founder of The Natural Step framework for strategic sustainable development.
-
E.
Carl Emil Wilhelm Andersson
Carl Emil Wilhelm Andersson, better known as Carl Milles, was a prominent Swedish sculptor renowned for his expressive fountains and monumental public works in the early 20th century.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
academic
ⓘ
cancer researcher ⓘ human ⓘ molecular biologist ⓘ science administrator ⓘ university professor ⓘ |
| academicDiscipline | medical biochemistry ⓘ |
| countryOfCitizenship | Sweden ⓘ |
| educatedAt | Uppsala University ⓘ |
| employer |
Ludwig Institute for Cancer Research
ⓘ
Uppsala University ⓘ |
| familyName | Heldin ⓘ |
| fieldOfWork |
cancer biology
ⓘ
cell biology ⓘ growth factors ⓘ molecular biology ⓘ platelet-derived growth factor ⓘ signal transduction ⓘ |
| givenName | Carl-Henrik ⓘ |
| hasReceivedAward |
Anders Jahre Award for Medical Research
ⓘ
Crafoord Prize in Polyarthritis (as committee member, not laureate) ⓘ
linked to:
Crafoord Foundation
Fernström Foundation Nordic Prize ⓘ Jubilee Prize of the Swedish Cancer Society ⓘ K. Albin Johansson Research Prize ⓘ Lennart Nilsson Award ⓘ Meyenburg Prize ⓘ |
| knownFor |
research on cancer mechanisms
ⓘ
research on cell growth regulation ⓘ research on platelet-derived growth factor ⓘ |
| languageSpoken |
English
ⓘ
Swedish ⓘ |
| memberOf |
Academia Europaea
ⓘ
European Molecular Biology Organization ⓘ Finnish Society of Sciences and Letters ⓘ
linked to:
Finnish Academy of Science and Letters
Norwegian Academy of Science and Letters ⓘ Royal Swedish Academy of Sciences ⓘ |
| name | Carl-Henrik Heldin ⓘ |
| nationality | Swedish ⓘ |
| positionHeld |
chairman of the Board of the Nobel Foundation
ⓘ
chairman of the Nobel Foundation ⓘ chairman of the Science for Life Laboratory board ⓘ director of the Ludwig Institute for Cancer Research in Uppsala ⓘ professor at Uppsala University ⓘ vice president of the European Research Council Scientific Council ⓘ |
| researchInterest |
oncogenic signaling pathways
ⓘ
receptor tyrosine kinases ⓘ transforming growth factor beta signaling ⓘ |
| sexOrGender | male ⓘ |
| workLocation |
Uppsala, Sweden
ⓘ
linked to:
Uppsala
|
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Carl-Henrik Heldin Description of subject: Carl-Henrik Heldin is a Swedish molecular biologist renowned for his research on cell growth and cancer, particularly involving platelet-derived growth factor (PDGF), and for his leadership roles in major scientific institutions.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.